159 related articles for article (PubMed ID: 20888459)
1. Kasabach-Merritt phenomenon.
Kelly M
Pediatr Clin North Am; 2010 Oct; 57(5):1085-9. PubMed ID: 20888459
[TBL] [Abstract][Full Text] [Related]
2. Capillary-lymphatic malformation, kaposiform hemangioendothelioma and delayed Kasabach-Merritt phenomenon.
del Pozo J; López-Gutiérrez JC; Gómez-Tellado M; Nistal M; Soler R; Sacristán F; Tovar JA
Pediatr Dermatol; 2011; 28(4):439-43. PubMed ID: 20403115
[TBL] [Abstract][Full Text] [Related]
3. Kaposiform hemangioendothelioma with Kasabach-Merritt syndrome: a new indication for propranolol treatment.
Hermans DJ; van Beynum IM; van der Vijver RJ; Kool LJ; de Blaauw I; van der Vleuten CJ
J Pediatr Hematol Oncol; 2011 May; 33(4):e171-3. PubMed ID: 21516018
[TBL] [Abstract][Full Text] [Related]
4. Kaposiform hemangioendothelioma arising in the deltoid muscle without the Kasabach-Merritt phenomenon.
Tamai N; Hashii Y; Osuga K; Chihara T; Morii E; Aozasa K; Yoshikawa H
Skeletal Radiol; 2010 Oct; 39(10):1043-6. PubMed ID: 20309545
[TBL] [Abstract][Full Text] [Related]
5. Rapidly involuting congenital hemangioma associated with profound, transient thrombocytopenia.
Rangwala S; Wysong A; Tollefson MM; Khuu P; Benjamin LT; Bruckner AL
Pediatr Dermatol; 2014; 31(3):402-4. PubMed ID: 22937785
[TBL] [Abstract][Full Text] [Related]
6. Kaposiform hemangioendothelioma (with Kasabach Merritt syndrome) of the head and neck: case report and review of the literature.
Mukerji SS; Osborn AJ; Roberts J; Valdez TA
Int J Pediatr Otorhinolaryngol; 2009 Oct; 73(10):1474-6. PubMed ID: 19643504
[TBL] [Abstract][Full Text] [Related]
7. Giant vascular malformation with thrombocytopenia in a newborn.
Downing A; Chauhan A; Lotterman C; Craver R; Warrier R
Clin Pediatr (Phila); 2013 Nov; 52(11):1079-82. PubMed ID: 24002050
[No Abstract] [Full Text] [Related]
8. Kaposiform hemangioendothelioma with Kasabach-Merritt phenomenon: from vincristine to sirolimus.
Jahnel J; Lackner H; Reiterer F; Urlesberger B; Urban C
Klin Padiatr; 2012 Oct; 224(6):395-7. PubMed ID: 23070861
[No Abstract] [Full Text] [Related]
9. Early surgical intervention in a patient with Kasabach-Merritt phenomenon.
Drolet BA; Scott LA; Esterly NB; Gosain AK
J Pediatr; 2001 May; 138(5):756-8. PubMed ID: 11343057
[TBL] [Abstract][Full Text] [Related]
10. Kaposiform hemangioendothelioma with Kasabach-Merritt phenomenon: successful treatment with embolization and vincristine in two newborns.
Garcia-Monaco R; Giachetti A; Peralta O; Napoli N; Lobos P; Gioseffi L; Mariani G
J Vasc Interv Radiol; 2012 Mar; 23(3):417-22. PubMed ID: 22365299
[TBL] [Abstract][Full Text] [Related]
11. Kaposiform hemangioendothelioma without Kasabach-Merritt phenomenon.
Gruman A; Liang MG; Mulliken JB; Fishman SJ; Burrows PE; Kozakewich HP; Blei F; Frieden IJ
J Am Acad Dermatol; 2005 Apr; 52(4):616-22. PubMed ID: 15793511
[TBL] [Abstract][Full Text] [Related]
12. [Kasabach-Merritt syndrome on a congenital tufted angioma].
Enjolras O; Wassef M; Dosquet C; Drouet L; Fortier G; Josset P; Merland JJ; Escande JP
Ann Dermatol Venereol; 1998 Apr; 125(4):257-60. PubMed ID: 9747263
[TBL] [Abstract][Full Text] [Related]
13. Successful management of Kaposiform hemangioendothelioma with Kasabach-Merritt phenomenon using vincristine and ticlopidine.
López V; Martí N; Pereda C; Martín JM; Ramón D; Mayordomo E; Jordá E
Pediatr Dermatol; 2009; 26(3):365-6. PubMed ID: 19706115
[TBL] [Abstract][Full Text] [Related]
14. Successful treatment of Kasabach-Merritt syndrome with vincristine and diagnosis of the hemangioma using three-dimensional imaging.
Hara K; Yoshida T; Kajiume T; Ohno N; Kawaguchi H; Kobayashi M
Pediatr Hematol Oncol; 2009; 26(5):375-80. PubMed ID: 19579084
[TBL] [Abstract][Full Text] [Related]
15. Kasabach-Merritt syndrome with partial resection of tumor, reduction of tumor blood, and vincristine chemotherapy.
Shen W; Cui J; Chen J; Zou J; Ji Y; Chen H
J Craniofac Surg; 2010 Jan; 21(1):215-6. PubMed ID: 20098187
[TBL] [Abstract][Full Text] [Related]
16. Vincristine-ticlopidine-aspirin: an effective therapy in children with Kasabach-Merritt phenomenon associated with vascular tumors.
Fernandez-Pineda I; Lopez-Gutierrez JC; Ramirez G; Marquez C
Pediatr Hematol Oncol; 2010 Nov; 27(8):641-5. PubMed ID: 20863161
[TBL] [Abstract][Full Text] [Related]
17. [Kasabach-Merritt phenomenon (KMP) exacerbated by platelet transfusions].
Korsaga-Somé N; Maruani A; Abdo I; Favrais G; Lorette G
Ann Dermatol Venereol; 2015 Oct; 142(10):578-80. PubMed ID: 25999262
[No Abstract] [Full Text] [Related]
18. Long-term outcome of vincristine-aspirin-ticlopidine (VAT) therapy for vascular tumors associated with Kasabach-Merritt phenomenon.
Fernandez-Pineda I; Lopez-Gutierrez JC; Chocarro G; Bernabeu-Wittel J; Ramirez-Villar GL
Pediatr Blood Cancer; 2013 Sep; 60(9):1478-81. PubMed ID: 23609996
[TBL] [Abstract][Full Text] [Related]
19. Kasabach-merritt phenomenon: case series and retrospective review of the mayo clinic experience.
Rodriguez V; Lee A; Witman PM; Anderson PA
J Pediatr Hematol Oncol; 2009 Jul; 31(7):522-6. PubMed ID: 19564750
[TBL] [Abstract][Full Text] [Related]
20. Kasabach-merritt phenomenon: a retrospective study of treatment with vincristine.
Haisley-Royster C; Enjolras O; Frieden IJ; Garzon M; Lee M; Oranje A; de Laat PC; Madern GC; Gonzalez F; Frangoul H; Le Moine P; Prose NS; Adams DM
J Pediatr Hematol Oncol; 2002; 24(6):459-62. PubMed ID: 12218593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
